Skip to main content

Advertisement

Fig. 1 | BMC Research Notes

Fig. 1

From: Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma

Fig. 1

Two representative cases harboring EGFR mutation by mutation-specific antibody against EGFR mutations in both epithelial and sarcomatoid components. a adenocarcinoma component in patient No. 2, ×20; b squamous cell carcinoma component in patient No. 2, ×20; c sarcomatoid component in patient No. 2, ×20; d sarcomatoid component in patient No. 15, ×20

Back to article page